INTRODUCTION
============

The achievement of efficient locomotory movements necessary for survival in a demanding external environment requires the integrated functioning and synergistic action of many muscle groups in order to ensure the appropriate positioning of all body regions during self-motion ([@B12]; [@B27]). However, most studies devoted to understanding locomotor control in humans and quadrupeds ([@B65]; [@B23]) have only addressed the functioning of the neural circuits controlling leg movements, and relatively little is known about the functioning of neuronal networks that activate trunk muscles in coordination with limb movements ([@B74]; [@B47]; [@B83]; [@B33]; [@B20]; [@B63]; [@B18]). Similarly, the role of the forelimbs during locomotion remains poorly understood ([@B1]; [@B22]; [@B2]; [@B79]). Indeed all these motor networks do not operate in isolation but interact with each other, and it is only recently that increasing attention has been paid to the interactive functioning of various spinal segments in quadrupedal mammals and humans during locomotion ([@B12]; [@B77]; [@B21]; [@B27], [@B26]; [@B56]; [@B61]).

Several seminal reviews ([@B38]; [@B58]) have recently highlighted the role of neuromodulators in governing the functional flexibility of spinal circuitry. The motor networks responsible for locomotor activity and which are the potential targets of neuromodulators are intrinsic to the spinal cord and can generate rhythmic motor activity in the absence of sensory feedback. The cervical and lumbar enlargements contain the neural machinery necessary to operate the fore- and hind-limbs, respectively, while thoracic and sacral segments control the axial systems. As underlined by [@B38], neuromodulatory actions are required for the normal function of these networks. In using the *in vitro* isolated spinal cord from new born rat, the neuromodulatory impact of the three biogenic amines serotonin, dopamine (DA), and noradrenaline (NA) on locomotion has been extensively studied. Their effect had been previously established for the motor activity generated by the lumbar segments and subsequent studies further investigated aspects of their pharmacological features ([@B14]; [@B44]; [@B45]; [@B70]; [@B3]; [@B57]; [@B62]; [@B32]; [@B55]). It has been shown that they may differentially modulate a motor pattern according to the specific receptor subtypes they activate (for review, see [@B58]). 5-HT exerts an excitatory (permissive) effect through an activation of 5-HT2 and 5-HT7 receptors ([@B57]; [@B62]; [@B55]) or an inhibitory (suppressive) action through 5-HT1 receptor activation ([@B6]) on motoneurons or interneurons ([@B80]). Similarly, NA ([@B45]; [@B70]), exerts a multi-modal control of lumbar locomotor networks through an α1 receptor mediated activation and an α2 receptors mediated inhibition ([@B70]; [@B29]; [@B32]). The dopaminergic modulation of lumbar locomotor patterns ([@B44]; [@B78]; [@B57]) is mediated via D1 and D2 receptor activation leading to an increase in motoneuron and Hb-9 interneuron excitability ([@B36]). Most of the effects reported for these drugs were also found to occur in spinally transected adult rodents ([@B50]; [@B51]; [@B53], [@B52]). Surprisingly, however, despite the numerous studies that have investigated the individual action of each amine alone or in combination with excitatory amino acids (EAAs), there has not been a study that has systematically compared the action of the three amines, alone or in various combinations, on locomotor pattern genesis.

The aim of the present study therefore was (1) to identify the neuromodulator mixture that most strongly activates spinal motor networks involved in hindlimb and axial muscle control; (2) to investigate how the biogenic amines serotonin (5-HT), DA, and NA, shape the operation of and the interactions between the limb and axial motor networks during ongoing locomotor-like rhythmogenesis initiated by excitatory amino-acid receptor activation.

MATERIALS AND METHODS {#s1}
=====================

Experiments were performed on the *in vitro* isolated spinal cord of newborn Sprague--Dawley rats aged between 1 and 5 post-natal days (P1--P5,*n* = 25 preparations). All procedures were conducted in accordance with the local ethics committee of the University of Bordeaux and the European Committee Council Directive. All efforts were made to minimize animal suffering and to reduce the number of animals.

*IN VITRO* ISOLATED SPINAL CORD
-------------------------------

Rat pups were anesthetized using isofluorane until no reflex could be elicited in response to tail or toe pinching. Animals were decapitated, the skin of the back removed, and the preparations were placed ventral side up in a dissecting chamber. A laminectomy was performed to expose the spinal cord that was then dissected out using fine forceps and microscissors under binocular microscope control. Dissections and recording procedures were performed under the continuous perfusion of an artificial cerebrospinal fluid (aCSF) equilibrated with 95% O~2~--5% CO~2~, pH7.4 at room temperature (24--26^∘^C) and containing (mM): NaCl 130, KCl 3, CaCl~2~ 2.5, MgSo~4~ 1.3, NaH~2~PO~4~ 0.58, NaHCO~3~ 25 and glucose 10. Spinal cords were sectioned at the T2 level at the beginning of the experiment.

ELECTROPHYSIOLOGICAL RECORDINGS AND ANALYSIS
--------------------------------------------

Extracellular motor activities were recorded from various spinal cord ventral roots using Vaseline-insulated, stainless steel pin electrodes at the lumbar level and glass suction electrodes for the shorter thoracic ventral roots. Recorded activities were amplified using custom-made amplifiers then digitized (Digidata 1322A, Molecular Device, CA, USA) using an interface driven by Axograph software (Axograph, AU). The raw signals were high-passed (50 Hz), rectified and integrated before analysis. Burst amplitudes (trough to peak) and locomotor pattern cycle periods were calculated using a program developed in Matlab (Mathworks) based on burst onset and offset detection. Since it is not possible to compare absolute amplitude values of extracellular data between experiments, we calculated only the relative change in amplitude from a control condition. Such amplitude changes could be either due to changes in firing frequency of already active motor units or to a recruitment of previously silent units. Due to the difficulty in establishing stable and persistent rhythmic locomotor-like activity with bath-application of EAAs alone, the combination of EAAs and 5-HT that is the most commonly used cocktail to induce locomotor-related activity *in vitro* ([@B71]) was taken as the reference condition to compare the actions of the amines.

We used recordings at L2 as the reference trace because it invariably exhibited the best signal-to-noise ratio. Pair-wise phase relationships between bursting activities recorded simultaneously from different ventral roots were calculated using wavelet transform analysis (for an extensive description of the method see [@B34]; [@B59]; [@B75]). For this purpose, we used custom-made software based on the MatLab wavelet coherence package provided by Aslak Grinsted (<http://noc.ac.uk/using-science/crosswavelet-wavelet-coherence>). For each pair-wise recording we performed both a cross wavelet transform and a wavelet coherence determination. The results obtained with both algorithms were combined into a single time-frequency map so as to extract phase relationships from delineated coherent common high power frequency regions. Phase values were plotted as a circular representation (0--1 rad), with the mean phase being indicated by the direction of the vector, and its length (range from 0 to 1) indicating the strength of the mean.

PHARMACOLOGY
------------

Episodes of locomotor-like activity were elicited by the exogenous application of a mixture of 15 μM N-methyl-[D,L]{.smallcaps}-aspartate (NMA, Sigma) and serotonin (5-HT, Sigma) and/or DA (Sigma), and/or NA (Sigma). DA and NA were freshly prepared and protected from light exposure during bath superfusion in order to prevent photo-degradation. Sodium metabisulfite (0.1%; Sigma) was also added to the DA supply in order to prevent oxidation ([@B3]). Drugs were bath-applied using a peristaltic pump (flow rate 4 ml/min; recording chamber volume 4 ml). The effects of the drugs were monitored from 5 to 10 min after reaching the Petri dish (the time required for total replacement of the normal saline and diffusion into the tissue).

Different drug combinations were tested on the same preparation in a random order except for DA. Since we previously demonstrated that high DA concentrations (500 μM) may exert long-lasting effects on the *in vitro* newborn rat spinal cord ([@B3]), this amine was always tested after the other amines in a given experiment and at a 10 times lower concentration than that found to exert prolonged actions (i.e., 50 μM instead of 500 μM). When different drug concentrations were tested in the same preparation, we always began with the lowest concentration. Total drug application lasted 20 min. During an episode of locomotor-like activity, cycle periods were initially longer and then shortened progressively until stable rhythmicity was reached within 5 min ([@B71]; [@B15]). All measurements were performed on 30 consecutive cycles during this steady-state condition. Each drug bath-application was followed by a prolonged wash out with normal saline for at least 30 min.

STATISTICAL ANALYSIS
--------------------

Data were tested for normality, and in its absence, non-parametric analysis was applied. Statistical analyses were performed using Prism software (Graphpad software, CA, USA). The coefficient of variation (COV), known as "relative variability," was determined by the SD divided by the mean and expressed as a percent. In each experiment it was calculated from the same recording sequence as the motor period and amplitude. The degree of variability (or stability) of the motor pattern cycle period was assessed by computing the COV. Comparisons between conditions were performed using Student's *t*-test, one-way or two-way ANOVA with Tukey's test *post hoc* analysis. The equality of group variance was tested using the Bartlett's test or the *F* test.

Statistical analyses of circular data were performed on raw data by descriptive statistics of circular distribution using IgoPro software (Wavemetrics, OR, USA) and Oriana software (KCS, UK). The Rayleigh test was used to determine the coupling strength. The Watson--Williams test (a circular analog of the one-factor ANOVA, [@B7]) and a non-parametric second-order two-sample test (which is less sensitive to departure from normality) consisting of pre-processing where the grand mean is subtracted from the two inputs followed by application of Watson's *U*2-test (IgoPro software, Wavemetrics, OR, USA) were used.

The significance threshold was taken to be *p* \< 0.05 unless otherwise specified. All data values in the text are means ± SEM.

RESULTS
=======

Since no direct comparison of the neuromodulatory action of the three monoamines 5-HT, NA and DA has been so far reported, we first established how they each modulate the basic rhythmic motor activity elicited by EAAs. For this purpose we recorded ipsi- and contra-lateral L2 and L5 lumbar ventral roots to respectively monitor the flexor and extensor phases of the motor pattern cycle (**Figures [1A1--A3](#F1){ref-type="fig"}**). From a given experiment we selected representative episodes of locomotor-like activity with comparable cycle periods elicited by the conjoint bath-application of the EAA agonist NMA and one amine in order to highlight possible differences between other parameters (such as COV, phase relationship, and motor burst amplitude). Several parameters that characterize the ongoing locomotor patterned activity were then calculated, namely the cycle period (the time that separates the onsets of two successive bursts of activity, **Figure [1B](#F1){ref-type="fig"}**), the COV of cycle period which is an index of the temporal regularity of the motor pattern (**Figure [1C](#F1){ref-type="fig"}**) and the burst amplitude (**Figure [1D](#F1){ref-type="fig"}**). As previously found ([@B70]; [@B3]), there was a significant dose-dependent action for DA on cycle period (one-way ANOVA, *F* = 6.06, *p* = 0.0016) but not for NA (one-way ANOVA, *F* = 0.8, *p* = 0.5) and 5-HT (Student's *t*-test, *t* = 1.53, *p* = 0.14), over the range of concentrations tested. In the present study, subsequent experiments were performed using DA at 50 μM, an intermediate concentration in the dose-dependent range. When comparing the variance of cycle period in the presence of the three amines at the concentrations used in **Figure [1A](#F1){ref-type="fig"}** (and throughout the study), we found that values were significantly different (Bartlett's test for equal variance, Bartlett's statistics = 10.5, *p* = 0.005). This variability in cycle period revealed by the COV calculation (**Figure [1C](#F1){ref-type="fig"}**), was comparable for NMA/5-HT and NMA/DA (9.3 ± 1.3% and 11 ± 2%, respectively) while it was significantly higher for NMA/NA (20.7 ± 2.8%, one-way ANOVA, *F* = 10.5, *p* = 0.0002). For each amine, there was no evident dose-dependency for period variability. **Figure [1D](#F1){ref-type="fig"}** shows the relative changes in motor burst amplitude. For each trial, the mean burst amplitude of activity in an individual ventral root under NMA/5-HT was considered as the control condition and measurements under other pharmacological conditions were normalized to this value. Both DA and NA significantly increased the amplitude of flexor (L2) and extensor (L5) motor bursts. Altogether, these results confirm the previously reported individual effects of the amines on EAA-induced locomotor-related rhythmicity, although our comparative assessment indicates that each amine exerts a specific action on hindlimb motor network activity.

![**Comparison of lumbar locomotor network activation *in vitro* by 5-HT, or DA or NA. (A)** Each amine was added to the bathing saline containing the NMDA excitatory amino acid receptor agonist NMA (15 μM), while extracellular recordings were made from the second left and right lumbar ventral root (lL2, rL2) and the fifth left lumbar ventral root (lL5) of the isolated spinal cord. **(B)** Plots of mean cycle period value obtained for different amine concentrations. A dose-dependent effect is only observable for DA. **(C)** Plots of the coefficient of variation (COV) of cycle period for each amine (NMA 15 μM, 5-HT 15 μM, DA 50 μM, NA 50 μM), indicating that NA leads to a more unstable motor activity. **(D)** Plots of mean relative amplitude changes normalized to the amplitude observed in the NMA/5-HT condition (green bar). DA and NA elicit larger burst amplitude in the lumbar ventral roots. In this and in subsequent figures, the number on each bar histogram indicates the number of experiments. ^∗^*p* \< 0.05.](fncir-08-00099-g001){#F1}

In a next step, we tested which amine most strongly activates the axial and hindlimb motor networks. **Figure [2A](#F2){ref-type="fig"}** presents typical simultaneous recordings from thoracic (T6 and T11), lumbar (L2) and sacral (S1, S3) ipsilateral ventral roots obtained from the same experiment in the presence of NMA and successively 5-HT (A1), DA (A2), and NA (A3) at amine concentrations that elicited motor rhythms with similar cycle periods. Each amine elicited coordinated motor burst at all segmental levels, although with qualitative differences. Visual trace inspection suggests that the most striking changes took place in the sacral burst amplitude in the presence of DA and especially NA. In the thoracic region, motor bursts were more distinguishable in the presence of 5-HT than either DA or NA. **Figure [2B](#F2){ref-type="fig"}** indicates the proportion of experiments in which motor bursts were recorded from thoracic and sacral segments when sustained lumbar locomotor-like activity was elicited as defined in **Figure [1](#F1){ref-type="fig"}**. In this respect, 5-HT and NA were noticeably more effective than DA. Moreover, relative amplitude calculations indicate that burst amplitudes in thoracic segments were significantly decreased by DA (**Figure [2C](#F2){ref-type="fig"}**; paired Student's *t*-test, *t* = 5.4, *p* = 0.0002), while burst amplitude in the sacral segments was significantly increased by DA (**Figure [2C](#F2){ref-type="fig"}**; paired Student's *t*-test, *t* = 2.8, *p* = 0.03) and NA (**Figure [2C](#F2){ref-type="fig"}**; Student's *t*-test, *t* = 4.5, *p* = 0.006).

![**Comparison of axial locomotor network activation *in vitro* by 5-HT, or DA or NA. (A)** Each amine was added to 15 μM NMA-containing saline during recordings from the sixth and eleventh left thoracic ventral roots (lT6, lT11), the second left lumbar ventral root (lL2), and the first and third left sacral ventral roots (lS1, lS3). **(B)** Plots indicating the percentage of experiments in which rhythmic motor activity was observed at a given segmental level. In these experiments, lumbar locomotor activity was always expressed. **(C)** Plots of mean relative amplitude changes normalized to the amplitude observed in the NMA/5-HT condition (green bar). Note the higher noradrenergic sensitivity of the more distal segments. ^∗^*p* \< 0.05.](fncir-08-00099-g002){#F2}

Since the combination of NMA and the amines elicited coordinated rhythmic motor activity in the various spinal cord areas, we examined whether, in addition to their effects on cycle period and burst amplitude, they were able to shape locomotor-related activity by modulating the phase relationships between the various segmental levels. Phase relationships were calculated by taking the ipsilateral L2 ventral root recording as the reference trace (see Materials and Methods). **Figure [3A](#F3){ref-type="fig"}** presents averaged individual cycles replicated in a continuous sequence to reveal the rhythmic nature of the activity (see Figure 6A in [@B25]), in the presence of each of the three amines. Each time a burst was detected in the reference L2 trace, it was sampled with the other associated recorded traces. Individual cycles were superimposed and then averaged. This process allowed switching from a continuous mode of recording to an episodic one (**Figures [3A](#F3){ref-type="fig"}** and **[4B](#F4){ref-type="fig"}**) so as to increase the signal-to-noise ratio in order to obtain a more accurate detection of burst peaks ([@B25]). None of the amines elicited significantly different phase relationships in the lumbar left/right alternating pattern, the flexor and extensor coordination nor burst durations, as indicated by the strict superimposition of L2 and L5 traces under all three amine conditions. In contrast, each amine established a distinct phase relationship between the thoracic, sacral and lumbar segments. **Figure [3B](#F3){ref-type="fig"}** illustrates the phase relationships between each recording location and reference L2. Data were pooled for all concentrations tested as there was no dose-dependent effect of concentration for any amine and any ventral root (multisample Watson--Williams test, *p* \> 0.1). Each point in the polar plots represents the mean phase value obtained in a single experiment, with the vector direction representing the mean phase value and its length the coupling strength. Inspection of the polar plots reveals that with 5-HT and DA, the phase values were more variable between experiments in the sacral region than in the lumbar or thoracic segments. In the presence of 5-HT there was a phase lag between lumbar and thoracic segments that was previously shown to increase significantly with the intervening distance ([@B25]), while almost synchronous bursting occurred in the recorded thoracic segments with no phase lag increase with segmental distance in the presence of DA (mean vector value 0.93 in T6 and 0.88 in T11; Mardia's two sample *U* 0.08, *p* \> 0.2, **Figure [3](#F3){ref-type="fig"}**) and NA (mean vector value 0.94 in T6 and 0.89 in T11; Mardia's two sample *U* 0.07, *p* \> 0.2, **Figure [3](#F3){ref-type="fig"}**). At the sacral level, a significant progressive phase shift relative to L2 occurred both in the presence of 5-HT (mean vector value 0.61 in S1 and 0.52 in S3; Mardia's two sample *U* 0.24, *p* \< 0.02, **Figure [3](#F3){ref-type="fig"}**), and DA (mean vector value 0.91 in S1, 0.61 in S3; Mardia's two sample *U* 0.3, *p* \< 0.005, **Figure [3](#F3){ref-type="fig"}**). In contrast, NA elicited a phase-locked motor pattern with a similar phase relationship at all sacral levels (mean vector value 0.97 in S1 and 0.93 in S3; Mardia's two sample *U* 0.18, *p* \> 0.05, **Figure [3](#F3){ref-type="fig"}**). These results therefore demonstrate that each amine possesses a specific instructive "signature" regarding its modulatory affect on the distributed temporal aspects of the motor pattern.

![**Control of phase relationships by 5-HT, DA, or NA. (A)** Averaged and replicated cycle sequences during locomotor-like activity induced by a combination of NMA (15 μM) and one of the three amines (5-HT, 15 μM; DA, 50 μM; NA, 50 μM). Bursts were normalized for the amplitude. Note phase differences relative to reference L2 bursts shift occurring in the thoracic and sacral segments. **(B)** Circular plots showing the mean phase values for burst activity in the six ventral roots recorded in A relative to the L2 ventral root in the presence of each three amines. Each point is the phase value measured from one experiment. The vector direction represents the grand mean phase value and its length is a function of the coupling strength. Data were pooled from all concentrations tested. i; ipsilateral; c, contralateral. ^∗^*p* \< 0.05.](fncir-08-00099-g003){#F3}

![**Control of activity phase relationships by various combinations of NMA and 5-HT/DA/NA. (A)** Simultaneous recordings of seven ventral roots in the presence of all four drugs. **(B)** Plots of mean cycle periods under various drug combinations. **(C)** Plots of mean relative amplitude changes normalized to the amplitude observed in the NMA/5-HT condition (green bar). **(D1)** Averaged and replicated cycles during locomotor-like activity induced by a combination of NMA (15 μM) and the three amines in various combinations. **(D2)** Circular plots calculated from the recordings in **D1** showing the mean phase values for the six ventral roots relative to L2 in the presence of NMA and the different amine cocktails. All data presented were obtained at the following drug concentrations: NMA, 15 μM; 5-HT, 15 μM; DA, 50 μM; NA, 50 μM. ^∗^*p* \< 0.05.](fncir-08-00099-g004){#F4}

Finally, we investigated different neuromodulatory combinations by mixing EAA receptor agonists with two or even the three amines (**Figure [4](#F4){ref-type="fig"}**). A typical experiment in which the four drugs were added to the bath saline is shown in **Figure [4A](#F4){ref-type="fig"}**. This neuromodulatory cocktail still elicited rhythmic motor output that, at a first glance, did not differ markedly from the condition with one amine alone. However, rhythmic bursting was less frequently observed (67% of experiments, **Table [1](#T1){ref-type="table"}**), in the thoracic compartment under the multiple amine condition. Moreover, the amines in combination elicited motor rhythms with significantly longer cycle periods (**Figure [4B](#F4){ref-type="fig"}**; unpaired Student's *t*-test; 5-HT/DA, *t* = 2.96, *p* = 0.0057; 5-HT/DA/NA, *t* = 6.82, *p* = 0.0001) and increased burst amplitude in the most caudal (L5 and sacral) segments (**Figure [4C](#F4){ref-type="fig"}**; paired Student's *t*-test; 5-HT/NA in L2, *t* = 2.5, *p* = 0.04; 5-HT/NA in L5, *t* = 2.5, *p* = 0.04; 5-HT/NA in S1, *t* = 4.8, *p* = 0.002; 5-HT/NA/DA in S1, *t* = 3.5, *p* = 0.017). The rhythm stability, as indicated by the COV was within the same range as values with the mixture of NMA/5-HT or NMA/DA (see **Figure [1C](#F1){ref-type="fig"}**), i.e. 10.4 ± 1.2% for NMA/5-HT/DA, 13 ± 2% for NMA/5-HT/NA and 12.6 ± 3.4% for NMA/5-HT/DA/NA. Moreover, phase analysis (**Figure [4D](#F4){ref-type="fig"}**), revealed that the flexor/extensor relationship remained extremely stable under all conditions (see also **Figure [3B](#F3){ref-type="fig"}**). In contrast, and especially for the sacral segments, the phase relationships generally became more variable with a very small vector length. Interestingly, however, in the mid-thoracic segment (T6), the phase relationships observed in the presence of all three amines or 5-HT/DA or 5-HT/NA was close to that observed in the presence of 5-HT alone (i.e., at about 0.19; see **Table [2](#T2){ref-type="table"}**).

###### 

Summary of the effects of 5-HT, DA and NA.

                   Episode duration       Period (s)    Period variability (%)   Relative Amplitude   Presence of motor bursts (%)                            
  ---------------- ---------------------- ------------- ------------------------ -------------------- ------------------------------ ------------- ---- ----- -----
  NMA                                     3.04 ± 0.5                                                                                                          
  NMA/5-HT         All bath-application   3.55 ± 0.10   9.30 ± 1.34              1                    1                              1             98   100   76
  NMA/DA 50μM      All bath-application   3.47 ± 0.24   11.04 ± 1.17             0.66 ± 0.06          1.40 ± 0.18                    1.54 ± 0.21   89   100   79
  NMA/NA 50μM      All bath-application   3.8 ± 0.16    20.68 ± 2.76             1.18 ± 0.29          1.22 ± 0.17                    2.68 ± 0.45   90   100   100
  NMA/5-HT/DA      All bath-application   4.41 ± 0.32   10.38 ± 1.79             0.96 ± 0.10          0.97 ± 0.06                    2.35 ± 0.57   85   100   78
  NMA/5-HT/NA      All bath-application   3.82 ± 0.36   13.03 ± 1.00             1.04 ± 0.11          1.24 ± 0.09                    2.81 ± 0.37   81   100   83
  NMA/5-HT/DA/NA   All bath-application   5.56 ± 0.42   12.65 ± 3.40             1.06 ± 0.17          1.09 ± 0.09                    3.35 ± 0.57   67   100   92

Note that the category "episode duration" indicates that a given neuromodulator cocktail induced rhythmic motor activity throughout bath-application.

###### 

Phase and mean vector length (*r*) value for burst activity in the six ventral roots (**Figure [4D2](#F4){ref-type="fig"}**) relative to the L2 ventral root in the presence of various combinations of NMA and 5-HT/DA/NA.

                   iT6              iT11              cL2              iL5              iS1              iS3
  ---------------- ---------------- ----------------- ---------------- ---------------- ---------------- ----------------
  NMA/5-HT         0.19 (31) 0.86   0.08 (31) 0.88    0.43 (28) 0.93   0.49 (18) 0.91   0.61 (15) 0.41   0.53 (9) 0.92
  NMA/DA           0.93 (39) 0.40   0.89 (45) 0.54    0.51 (47) 0.94   0.44 (38) 0.80   0.91 (25) 0.67   0.67 (13) 0.49
  NMA/NA           0.94 (21) 0.85   0.90 (23) 0.794   0.48 (26) 0.88   0.49 (23) 0.87   0.97 (21) 0.86   0.93 (13) 0.89
  NMA/5-HT/DA      0.19 (11) 0.90   0.12 (12) 0.63    0.48 (12) 0.71   0.49 (10) 0.61   0.41 (8) 0.18    0.30 (6) 0.27
  NMA/5-HT/NA      0.16 (5) 0.74    0.16 (8) 0.19     0.50 (8) 0.92    0.46 (8) 0.89    0.86 (8) 0.66    0.64 (5) 0.84
  NMA/5-HT/DA/NA   0.12 (3) 0.42    0.00 (5) 0.56     0.50 (6) 0.97    0.45 (5) 0.95    0.19 (6) 0.16    0.40 (6) 0.21

DISCUSSION
==========

COMBINATORY ACTION OF DRUGS ON MOTOR RHYTHM GENERATION AND STABILITY
--------------------------------------------------------------------

As pointed out by [@B35] there is a need in the field of spinal cord injury and recovery for elaborating therapeutic strategies based on drug-induced CPG activation. Hence the identification of candidate molecules that could become first-in-class treatments for spinal cord injured patients in animal models becomes a prerequisite. The first objective of the present work was therefore to determine which neuromodulator cocktail most effectively activates spinal motor networks involved in locomotion. In pioneering studies ([@B49]; [@B68]), the EAA receptor agonist NMDA was reported as the first molecule to evoke locomotor-like episodes in the isolated neonatal rat spinal cord. Later on, we established 5-HT as one of the main actors in locomotor network activation in rodents ([@B13], [@B14]), and discovered that the combined bath-application of 5-HT and EAA agonists was a very effective way to reliably elicit sustained episodes of locomotor-like activity ([@B72], [@B71]). Since then, it has become the most widely used method to eliciting locomotor-like activity in this preparation, and hundreds of reports have been released based on this seminal observation. In contrast, only few studies have documented the combined activating action of EAA/DA or EAA/DA/5-HT ([@B44]; [@B41]; [@B78]; [@B42]; [@B82]; [@B73]), or EAA/NA ([@B45]; [@B70]), and in each case there was no clear experimental rational for employing this combined EAA/amine approach. Surprisingly, despite the outstanding opportunity provided by the use of an *in vitro* preparation, no study has systematically addressed the issue of combined drug actions and no comparative study of permissive neuromodulator interactions is available. Although some idea of the influences of these amines together can be gleaned indirectly from the literature, the disparity in protocols used (saline composition, temperature, rat strain,...) has prevented a direct comparison to be made. Furthermore in most studies, motor output from only the lumbar cord region was investigated.

An important prerequisite is to clearly define the limits and the terms of what can be considered as the "optimal" form of locomotor output *in vitro*. There is a general consensus in the field that spinally generated rhythmic motor activity is considered as "locomotor-like" when alternating flexor and extensor bursts are recorded extracellularly from the L2 and L5 ventral roots ([@B14]; [@B44]) and when the pattern cycle period falls within a range similar to that observed in the intact animal at the same age (1s; [@B13]; [@B40]). However, caveats in the respect include the effect of temperature on the *in vitro* rhythm frequency, since from 25^∘^C (the typical mean room temperature used in most *in vitro* studies) to 35^∘^C (the usual pup body temperature and the temperature at which *in vivo* experiments are performed ([@B13]), the cycle period decreases by more than 50% ([@B72]). A similar observation has been reported for saline K^+^ concentration that is frequently twice the normal concentration (3 mM; [@B69]) measured in the intact animal. As such, the "best" *in vitro* motor output pattern would have a cycle period of ∼2--3 s (when taking into account the slowing down of the motor period resulting from the isolated CNS conditions), with fictive locomotor episodes lasting for the duration of drug bath-application (i.e., without receptor desensitization or any other processes that would prematurely curtail rhythmogenesis) and ventral root bursts that, in a given drug condition, occur as regularly as possible and with little variation both in their amplitude and inter-root phase relationships. Based on these premises, **Table [1](#T1){ref-type="table"}** summarizes the data collected in the present and previous studies. It includes data of thoracic, lumbar and sacral motor output and under exposure to various drug combinations. A comparison of the compiled values indicates that there is no optimal way to elicit locomotor-like activity *in vitro* since several neurotransmitter combinations are able to elicit stable rhythmicity with *in vitro* locomotor compatible periods and phase-relationships. For example, motor burst amplitude is evidently more sensitive to NA, whereas rhythm stability is provided by DA or 5-HT. Presumably such differences indicate that the various parameters of the spinal motor system can be separately adjusted according to changing behavioral requirements. Nevertheless, it remains apparent that the combination of EAA/5-HT constitutes a good compromise in terms of rhythm stability, burst amplitude, and the recruitment of the different spinal compartments. However, specifically for sacral activity, it would be perhaps more interesting to use NA or DA which elicit higher burst amplitudes. To date it is not possible to determine the location at which the neuromodulatory processes described here may occur. With increasing age, there is a decrease in the motor period variability in the intact animal ([@B13]). Both the bath-application technique used here and the developmental changes undergone by neuromodulatory pathways themselves do not allow us to draw any conclusion about the precise functional role played by each amine in the intact adult animal.

Rhythmic motor activity elicited by the conjoint bath-application of EAA agonists and the three amines separately or in combination always led to locomotor pattern genesis (**Figures [1](#F1){ref-type="fig"}** and **[4](#F4){ref-type="fig"}**). Our previous studies have already described the pharmacological action of the three amines and how they modulate NMA-induced locomotor-like activity ([@B71]; [@B70]; [@B3]). In the present study, the same NMA concentration was the common parameter for all conditions, thus allowing direct comparison to be made between the different amine actions. Of the three amines, however, only 5-HT triggered activity that corresponded most closely to actual locomotion in terms of cycle period and inter-segmental phase relationships. In contrast, neither NA nor DA alone evokes locomotor-compatible rhythms, the latter in terms of cycle periods ([@B44]; [@B3]) and the former in terms of cycle periods and flexor/extensor phase relationships ([@B45]; [@B70]; [@B30]). On this basis, therefore, it could be that the locomotor signature of spinal output rhythmicity is provided mainly by EAAs since the activity they elicit possess the closest parameters to the cycle periods and flexor and extensor alternation observed *in vivo* ([@B49]; [@B14]). In such a framework, EAAs could establish basal temporal features of the motor rhythm with a cycle period that varies according to the amount of endogenous EAA released ([@B49]; [@B14]; [@B5]; [@B73]). During real CPG operation, the main task of the amines would be to modulate this "primary" EAA-induced pattern via their combinatorial release.

To date, the cellular mechanisms by which the amines exert their effects remain unclear, although undoubtedly they will be multiple and complex ([@B38]). It is likely that each parameter set by an amine -- motor burst period, amplitude and stability -- involves various cellular targets. For example, all three amines strengthen burst activity, i.e. they increase the amplitude and regularity of bursting by increasing neuronal excitability at the motoneuronal and/or premotoneuronal levels ([@B8]; [@B70]; [@B46]; [@B29]; [@B81]; [@B36]).

Their dose-dependent action on rhythm cycle period ([@B14]; [@B70]) suggests that the amines directly access components of the spinal CPG itself. Moreover, since EAAs and amines individually increase neuronal excitability, it could be expected that the period of the motor rhythm induced by their combined presence would be even shorter than when each compound is acting separately. This was not the case, and indeed the cycle period was found to be set at an intermediate value between that evoked by EAA or the amine alone (**Figure [1](#F1){ref-type="fig"}**; **Table [1](#T1){ref-type="table"}**). Pharmacological data provide a partial explanation for the aminergic effect on cycle period, since as mentioned previously, both NA and 5-HT slow down the locomotor rhythm through an inhibitory action via α2 receptors ([@B70]; [@B30]), and 5-HT1 ([@B6]), while α1, 5-HT7, and 5-HT2 receptor agonists have an activatory action on pattern generation ([@B14]; [@B70]; [@B57]; [@B50]; [@B55]). Surprisingly, however, DA which has been reported solely to have activatory effects also slows down the EAA-induced spinal motor rhythm (**Figure [1](#F1){ref-type="fig"}**; [@B3]). Therefore, it is likely that several underlying processes are operating simultaneously, as reported in other preparations ([@B38]; [@B58]; [@B17]). For example, in the lamprey the serotonin-induced prolongation of motor burst duration and cycle period involves at least two mechanisms, presynaptic inhibition of glutamate release on CPG neurons ([@B66]) and post-synaptic blockade of sAHP ([@B76]; [@B24]).

AMINERGIC SHAPING OF THE SPINAL MOTOR PATTERN
---------------------------------------------

The physiology of locomotion in quadrupeds relies mostly on a simplified dichotomy between dynamic locomotor activity in which only hindlimb movements are considered and postural activity during static tasks. The main characteristics of locomotor-like rhythmic activity recorded in the *in vitro* spinal cord preparation essentially consist of burst cycle period, alternating left/right and flexor/extensor phase relationships, and burst duration. We found here that these parameters were amazingly constant whatever the neuromodulatory condition (**Figures [1](#F1){ref-type="fig"}** and **[4](#F4){ref-type="fig"}**; **Table [2](#T2){ref-type="table"}**). This lack of flexibility may reflect a real functional situation since during ongoing locomotion there is an absolute requirement for fundamental parameters such as right/left movement alternation to be strictly maintained on order preserve balance and speed. Alternatively, the apparent lack of modulator-induced flexibility may be attributable to an *in vitro* bias. In the isolated spinal cord preparation, simultaneous ventral root recordings provide only a global view of various temporally overlapping motor activities and, for example, the slightly differing temporal relationships that exist between various muscle groups, as has been observed with electromyographic recordings in the intact animal ([@B54]), may not be evident.

In several systems, interactions between distinct rhythmically active networks have been also described, as for example between walking and swimmeret movements in crustaceans ([@B11]; [@B16]), gastric and pyloric motor rhythms in the crustacean stomatogastric system ([@B4]; [@B28]), trunk and hindlimb activities in Xenopus ([@B9]; [@B63]), locomotion and respiration ([@B43]; [@B60]), scratching and locomotion ([@B37]), respiration and swallowing ([@B31]). In the newt, axial neuronal networks switch from sequential motor burst propagation to stationary phase-locked activation of the same axial muscles when the animal switches from swimming to quadrupedal locomotion ([@B19]). To date, however, the link between the systems level and the underlying cellular mechanisms has only been established in simpler invertebrate systems in which identified neurons can be individually activated and recorded ([@B10]; [@B67]). Indeed the pharmacological approach that we have used in the present study also has some limitations, especially when considering the temporal aspects of neuromodulation. During functioning in the intact animal it is likely that descending aminergic pathways are momentarily active whereas the pharmacological protocol used here necessarily consists of tonic, continuous bath-application that in turn leads to the disappearance of the temporal dimension of neuromodulation. A second limitation is the state dependence of the system when several bath-applications are performed on the same spinal cord. Indeed, for the NMA/5-HT combination, we observed in a previous study that successive applications elicited sequences of locomotor-like activity with the same characteristics ([@B15]). Exogenous DA has been shown in other systems to lead to persistent changes in ionic conductances ([@B64]; [@B48]), and we also reported in the isolated spinal cord preparation (see Materials and Methods, [@B3]) that it may exert long-lasting effects. It is for this reason that DA was always the last drug tested in our experiments and at a much lower concentration than that at which these long-lasting effects were previously observed. There is no evidence that NA exerts such persistent actions.

When considering the integrated functioning of hindlimb and axial networks involved in dynamic posture, a different perspective is required since as we demonstrate, this \<\<metanetwork\>\> can be configured into various functional states according to the neuromodulatory environment. As shown in **Figures [1](#F1){ref-type="fig"}** and **[2](#F2){ref-type="fig"}**, although the amines and EAAs have a qualitatively cumulative effect on rhythm stability and burst amplitude, each amine has its own characteristic imprint. DA and NA specifically enhance sacral motor bursts (**Figure [2](#F2){ref-type="fig"}**) while 5-HT and DA better stabilize the temporal parameters of the motor pattern (**Figure [1](#F1){ref-type="fig"}**). Each amine can also specify distinct phase relationships between the various spinal segments (**Figure [3](#F3){ref-type="fig"}**). In a previous study, in which only the action of a mixture of NMA/5-HT on the interconnected spinal networks was investigated, we found a constant lag between lumbar and thoracic segments, with a significant tendency for caudo-rostral propagation ([@B25]). Here, we find that DA and NA, in contrast to 5-HT's action, substantially decreases the phase lags along the cord so that almost synchronous bursting occurs throughout the spinal cord. Changes from rostro-caudal to caudo-rostral propagation are also observed in the lamprey, when switching from forward to backward swimming occurs ([@B39]). Although, the cellular targets have not been identified, spinal commissural interneurons could be one possible target as they are known to be modulated by 5-HT ([@B80]), and since we previously established in the neonatal rat that a partial or complete hemicord section suppressed the phase delays between sacral segments ([@B25]).

In conclusion, the present paper provides new data on the coordinating processes between spinal cord networks. We demonstrate that each of three amines 5-HT, DA, and NA, when associated with EAA receptor agonists elicits a specific locomotor pattern whose temporal characteristics, motor burst amplitude and intersegmental phase relationships have a distinct signature. These differences are likely to be related to changing behavioral requirements. Furthermore, we find here that the various amines acting in combination do not elicit more robust locomotor-like activity than when bath-applied alone (i.e., more is not better!). The aminergic neuromodulators thus represent an important potential source of adaptive flexibility at the level of the underlying central neuronal networks and the motor output patterns they produce.
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